Latest Intellectual Property News

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.

Firebird Metals has made significant strides in its lithium manganese iron phosphate (LMFP) battery strategy, unveiling a new lab-scale cathode production facility and securing key patents. The company also demonstrated major energy savings in kiln trials, positioning itself strongly in the evolving battery materials market.

Talga Group has cemented its position in the European battery materials sector by securing full mining rights for its Nunasvaara South graphite mine and signing a binding supply agreement with fast-charging battery pioneer Nyobolt.

Reward Minerals Limited is progressing its innovative potash processing technologies while simultaneously advancing exploration of its 100% owned Kalgoorlie gold projects, supported by a solid cash position of $1.738 million.

Element 25 Limited has locked in AU$50 million in senior debt from the Northern Australia Infrastructure Facility to expand its Butcherbird manganese project, while advancing its US battery-grade manganese refinery with significant government grants and patent protections.

Impact Minerals reports a robust Preliminary Feasibility Study for its Lake Hope High Purity Alumina project, underpinned by strong economics and low production costs, while strategically acquiring a 50% stake in Alluminous Pty Ltd to fast-track market entry with HiPurA® technology.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

Aeeris Ltd reported a strong Q4 FY25 with a 13.3% increase in annual recurring revenue, driven by the full deployment of its proprietary AWARE system and strategic in-house service transitions.

Locate Technologies Limited reported a significant cash burn in its latest quarterly cash flow report, highlighting ongoing operational and investing outflows amid stable financing arrangements.

BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.

Immutep Limited advances its pivotal Phase III lung cancer trial and reports promising results across multiple oncology and autoimmune programs, supported by a solid cash position to fund operations through 2026.

EcoGraf Limited has advanced its vertically integrated battery anode materials business with a US$105 million financing mandate for its Epanko Graphite Mine and positive momentum in US and EU government support.